We report to our partners weekly. We will report to you the same way.
The case studies below are real engagements with real numbers, pulled from the same tracking we send our partners every week. Names are withheld out of respect for our partners' competitive position. If the work looks like what your brand needs, we are happy to walk you through the detail on a call.
Case study 1: United States market entry
A United Kingdom predictive genetics company needed United States traction, without building a United States team.
The situation. A United Kingdom diagnostics company with a clinically validated cardiovascular genetics portfolio needed United States commercial momentum. Their buyers are cardiologists, lipid specialists, and health system decision makers, an audience that does not answer generic outreach.
What we did. Full commercial program: prospect list building and individual enrichment, personalized outreach across email, LinkedIn, voice notes, and phone, senior reps on every conversation, and a native-domain sending mailbox inside the client's own email system for deliverability and trust.
The first six months, by the numbers
The outcome. 24 opportunities advanced to qualified stage or beyond in the first six months, including meetings with cardiology practices and health systems. The program is now scaling week over week.
Case study 2: pipeline for a bioanalytical assay supplier
An immunoassay supplier needed consistent pipeline with pharma and contract research buyers.
The situation. A supplier of ELISA kits and bioanalytical services for PK and immunogenicity work needed steady top-of-funnel activity with bioanalytical scientists and contract research decision makers, an audience that ignores generic outreach entirely.
What we did. Multi-channel lead generation with individual enrichment on every prospect, LinkedIn voice notes for high-value targets, and phone follow-up by a dedicated rep.
The first five months, by the numbers
The outcome. Eight meetings with pharma and contract research decision makers, built from a standing start in a market where a single validated assay partnership is worth six figures a year.
Case study 3: speed to activity for a European preclinical CRO
A European preclinical contract research organization wanted North American conversations, fast.
The situation. An established European preclinical contract research organization wanted North American awareness and conversations without waiting on a hiring cycle.
What we did. Launched a full four-channel program from a standing start, with senior scientists' inboxes and LinkedIn feeds as the battleground.
The first eight weeks, by the numbers
The outcome. One in four accepted connections replied to a follow-up message. Alongside LinkedIn, the phone program produced more than 1,500 dials and over 600 live conversations in the same eight weeks. Awareness first, pipeline building behind it.